Cancel
Daniel C. Pevear
Founder and Senior Vice President, Biology and Grants Development
@
Venatorx Pharmaceuticals
j.9s4sij@6k5u7k92.gfi
Sign up to see email
Known information
- Has over 25 years of experience in anti-infectives drug discovery and development.
- Was the Director of Biology at Protez Pharmaceuticals, a subsidiary of Novartis Pharmaceuticals Corporation.
- Co-led the team that advanced a first-in-class beta-lactamase inhibitor into preclinical development at Protez Pharmaceuticals.
- Directed a billion-dollar collaboration with Alnylam Pharmaceuticals on RNA interference technology while at Novartis Pharmaceuticals.
- Worked at Progenics Pharmaceuticals, directing research efforts in Human immunodeficiency virus and Hepatitis C virus.
- Was a founding scientific team member of ViroPharma Inc. in 1994.
- Led a team of over 30 scientists at ViroPharma working on various anti-infective targets.
- Advanced a first-in-class inhibitor for common cold viruses through NDA filing while at ViroPharma.
- Worked at Sterling Winthrop Research Institute from 1988 to 1994.
- Published over 80 papers in peer-reviewed journals.
- Written more than a half dozen reviews.
- Served as Principal Investigator and/or written 6 SBIR-Advanced Technology awards.
- Contributed to several other SBIR-Advanced Technology awards.
- Served as an NIH Center for Scientific Review Special Emphasis Panel Member for AIDS SBIR applications in 2005.
- Received a Ph.D. in Viral Immunology from Rensselaer Polytechnic Institute in 1984.
- Was a Postdoctoral Fellow of the National Multiple Sclerosis Society in the lab of Dr. Howard Lipton at Northwestern University Medical School from 1985 to 1988.
About Venatorx Pharmaceuticals
Venatorx Pharmaceuticals, founded in June 2010, focuses on developing novel anti-infectives to treat multi-drug-resistant bacterial and hard-to-treat viral infections. Their lead asset, cefepime-taniborbactam, has completed a Phase 3 study for complicated urinary tract infections and is under FDA review.
Report inaccurate information